Joseph Kaiser

Pharmacist



  
  705 E Main Ave Ste 200, Bismarck
North Dakota, 58501-4525

 701-222-3360   
Joseph Kaiser is a pharmacist in Bismarck, North Dakota. Patients can reach him at 705 E Main Ave Ste 200, Bismarck or contact him on 701-222-3360. Active license number of Joseph Kaiser is RPH5667 for Pharmacist in North Dakota.
Joseph Kaiser is


Complete Profile:
Joseph Kaiser speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Joseph Kaiser
Specialization: Pharmacist
Credentials:PHARMD
Gender:Male
Location:705 E Main Ave Ste 200, Bismarck,
North Dakota, 58501-4525
Phone:701-222-3360
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Joseph Kaiser are as mentioned below.
NPI Number: 1871288324
NPI Enumeration Date: 10 Apr, 2023
NPI Last Update On: 10 Apr, 2023

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Joseph Kaiser are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist RPH5667North DakotaPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 705 E Main Ave Ste 200,
Bismarck, North Dakota
Zip: 58501-4525
Phone Number: 701-222-3360
Patients can reach Joseph Kaiser at 705 E Main Ave Ste 200, Bismarck, North Dakota or can call on phone at 701-222-3360.

Comments/ Reviews:
Read all the reviews posted for Joseph Kaiser below. You may also share your own experience with Joseph Kaiser. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.